2-Chloro-5-Iodobenzoic Acid CAS 19094-56-5 Empagliflozin Intermediate Assay ≥99.0% (HPLC)

Tsanangudzo Pfupi:

Zita reKemikari: 2-Chloro-5-Iodobenzoic Acid

CAS: 19094-56-5

Chiyero: ≥99.0% (HPLC)

Chitarisiko: Makristasi Machena kana Machena Yellow

Yepakati yeMpagliflozin (CAS: 864070-44-0) yekurapa chirwere cheshuga chechipiri

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Tumira email kwatiri

Product Detail

Product Tags

Tsanangudzo:

Manufacturer Supply, High Purity, Commercial Production
Zita reKemikari: 2-Chloro-5-Iodobenzoic Acid
CAS: 19094-56-5

Chemical Properties:

Chemical Name	2-Chloro-5-Iodobenzoic Acid
Nhamba yeCAS	19094-56-5
Nhamba yeCAT	RF-PI438
Stock Status	MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula	C7H4ClIO2
Molecular Weight	282.46
Solubility	Soluble muMethanol
Brand	Ruifu Chemical

Zvinotsanangurwa:

Item	Zvinotsanangurwa
Chitarisiko	Makristasi Machena kana Machena Yellow
Assay / Analysis Method	≥99.0% (HPLC)
Melting Point	161.0~163.0℃
Kurasika paKuomesa	≤0.50%
Residue paIgnition	≤0.20%
Zvose Zvisina Kuchena	≤1.0%
Heavy Metals	≤20ppm
Residual Solvent	Ethanol
Test Standard	Enterprise Standard
Usage	Yepakati yeMpagliflozin (CAS: 864070-44-0)

2-Chloro-5-Iodobenzoic Acid (CAS 19094-56-5) Synthetic Route

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro.

Zvakanakira:

FAQ:

Application:

2-Chloro-5-Iodobenzoic Acid (CAS: 19094-56-5) inogona kushandiswa semushonga wepakati mune synthesis yeMpagliflozin (CAS: 864070-44-0).Empagliflozin (zita rekutengesa Jardiance) inhibitor ye sodium glucose co-transporter-2 (SGLT-2), uye inoita kuti shuga muropa ibudiswe neitsvo uye ichibviswa muweti.Musi waNyamavhuvhu 1, 2014, iyo Chikafu neDrug Administration (FDA) yakabvumidza zviri pamutemo mushonga wekurapa chirwere cheshuga cherudzi rwechipiri, kuvandudza nekudzora shuga yeropa revakuru.Empagliflozin ndiyo yechitatu SGLT-2 inhibiting mishonga inotenderwa neFDA.Mimwe mishonga miviri yeSGLT-2 inhibitor, Canagliflozin uye Dapagliflozin, yeJohnson Pharmaceuticals, AstraZeneca neBristol-Myers Squibb zvichiteerana, inotenderwa neFDA muna Mbudzi 2013 naNdira 2014 zvichiteerana.